PTEN - PTEN hamartoma tumor syndrome

This test is available for the following conditions:

  • Conditions > Multiple congenital anomalies (MCA) > PTEN Hamartoma Tumor syndrome
  • Conditions > Oncogenetics > PTEN Hamartoma Tumor syndrome

This product is also part of the following panels:

  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • panel polyposis (APC, MUTYH, SMAD4, BMPR1A, POLE, POLD1, NTHL1, STK11, PTEN)
  • WES hereditary cancer (% *)
  • WES intellectual disability (% *)
  • WES Mendelian inherited disorders (% *)
  • WES metabolic disorders (% *)
  • WES skin disorders¹ (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 601728
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 656

Gene

PTEN - PTEN hamartoma tumor syndrome

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 656

PTEN - PTEN hamartoma tumor syndrome



€ 656